Kamu erişimi zorunlu olan makaleler - Ariel Dora SternDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 2
Effects of remote patient monitoring use on care outcomes among medicare patients with hypertension: an observational study
M Tang, CH Nakamoto, AD Stern, JR Zubizarreta, FO Marcondes, ...
Annals of internal medicine 176 (11), 1465-1475, 2023
Zorunlu olanlar: US National Institutes of Health
Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510 (k) Clearance—Reply
AO Everhart, Y Zhu, AD Stern
JAMA 329 (18), 1609-1610, 2023
Zorunlu olanlar: US National Institutes of Health, Arnold Ventures LLC
Bir yerde sunuluyor: 23
Physician beliefs and patient preferences: a new look at regional variation in health care spending
D Cutler, JS Skinner, AD Stern, D Wennberg
American Economic Journal: Economic Policy 11 (1), 192-221, 2019
Zorunlu olanlar: US National Institutes of Health
Adaptive platform trials: definition, design, conduct and reporting considerations
Nature Reviews Drug Discovery 18 (10), 797-807, 2019
Zorunlu olanlar: US National Institutes of Health
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
S Gerke, AD Stern, T Minssen
NPJ digital medicine 3 (1), 94, 2020
Zorunlu olanlar: Knut and Alice Wallenberg Foundation
Innovation under regulatory uncertainty: Evidence from medical technology
AD Stern
Journal of public economics 145, 181-200, 2017
Zorunlu olanlar: US National Institutes of Health
Evaluating the impact of the Baby-Friendly Hospital Initiative on breast-feeding rates: a multi-state analysis
SS Hawkins, AD Stern, CF Baum, MW Gillman
Public health nutrition 18 (2), 189-197, 2015
Zorunlu olanlar: US National Institutes of Health
Advancing digital health applications: priorities for innovation in real-world evidence generation
AD Stern, J Brönneke, JF Debatin, J Hagen, H Matthies, S Patel, I Clay, ...
The Lancet Digital Health 4 (3), e200-e206, 2022
Zorunlu olanlar: US National Institutes of Health, Gordon and Betty Moore Foundation, German …
Health app policy: international comparison of nine countries’ approaches
A Essén, AD Stern, CB Haase, J Car, F Greaves, D Paparova, S Vandeput, ...
NPJ digital medicine 5 (1), 31, 2022
Zorunlu olanlar: National Institute for Health Research, UK
Compliance with the Baby-Friendly Hospital Initiative and impact on breastfeeding rates
SS Hawkins, AD Stern, CF Baum, MW Gillman
Archives of Disease in Childhood-Fetal and Neonatal Edition 99 (2), F138-F143, 2014
Zorunlu olanlar: US National Institutes of Health
The impact of the entry of biosimilars: evidence from Europe
FM Scott Morton, AD Stern, S Stern
Review of Industrial Organization 53, 173-210, 2018
Zorunlu olanlar: US National Science Foundation, US National Institutes of Health
Do state breastfeeding laws in the USA promote breast feeding?
SS Hawkins, AD Stern, MW Gillman
J Epidemiol Community Health 67 (3), 250-256, 2013
Zorunlu olanlar: US National Institutes of Health
Federated electronic health records for the European Health Data Space
R Raab, A Küderle, A Zakreuskaya, AD Stern, J Klucken, G Kaissis, ...
The Lancet Digital Health 5 (11), e840-e847, 2023
Zorunlu olanlar: German Research Foundation, European Commission, Federal Ministry of …
Lessons from the impact of price regulation on the pricing of anticancer drugs in Germany: study assesses the effects of female political representation on mortality among …
VD Lauenroth, AS Kesselheim, A Sarpatwari, AD Stern
Health Affairs 39 (7), 1185-1193, 2020
Zorunlu olanlar: Arnold Ventures LLC
Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping
R van Kessel, D Srivastava, I Kyriopoulos, G Monti, D Novillo-Ortiz, ...
JMIR mHealth and uHealth 11 (1), e49003, 2023
Zorunlu olanlar: Vinnova, Sweden
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users: Study examines the early years of entry of biosimilar and related follow-on products …
AD Stern, JL Chen, M Ouellet, MR Trusheim, Z El-Kilani, A Jessup, ...
Health Affairs 40 (6), 989-999, 2021
Zorunlu olanlar: US National Institutes of Health
The impact of price regulation on the availability of new drugs in Germany
AD Stern, F Pietrulla, A Herr, AS Kesselheim, A Sarpatwari
Health Affairs 38 (7), 1182-1187, 2019
Zorunlu olanlar: Arnold Ventures LLC
Trends in remote patient monitoring use in traditional Medicare
M Tang, CH Nakamoto, AD Stern, A Mehrotra
JAMA Internal Medicine 182 (9), 1005-1006, 2022
Zorunlu olanlar: US National Institutes of Health
Innovation incentives and biomarkers
AD Stern, BM Alexander, A Chandra
Clinical Pharmacology & Therapeutics 103 (1), 34-36, 2018
Zorunlu olanlar: US National Institutes of Health, Wellcome Trust
AI insurance: how liability insurance can drive the responsible adoption of artificial intelligence in health care
AD Stern, A Goldfarb, T Minssen, WN Price II
NEJM Catalyst Innovations in Care Delivery 3 (4), CAT. 21.0242, 2022
Zorunlu olanlar: Knut and Alice Wallenberg Foundation
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir